When Should the Treatment of Obesity in Thyroid Disease Begin?
- PMID: 39857741
- PMCID: PMC11760466
- DOI: 10.3390/biomedicines13010157
When Should the Treatment of Obesity in Thyroid Disease Begin?
Abstract
Obesity often coexists with thyroid diseases, and the prevalence of these disorders has been on the rise for years. While hypothyroidism can contribute to excess fat tissue, the relationship between Body Mass Index (BMI) and thyroid function hormones is bidirectional. Research confirms that fat tissue reduction can positively impact thyroid function. Thus, delaying the initiation of therapies beyond substitution treatment to achieve optimal weight reduction in individuals with thyroid dysfunction seems unwarranted. The authors summarize current knowledge on this topic in the article.
Keywords: obesity; obesity treatment; thyroid; thyroid hormones.
Conflict of interest statement
E.S. and A.Z.-K. are lecturers for pharmaceutical companies Eli Lilly and Novo Nordisk; the article was not sponsored nor created at the request of these companies; M.K.—no conflicts of interest.
References
-
- Obesity and Overweight. [(accessed on 30 October 2024)]. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
-
- Obesity. [(accessed on 30 October 2024)]. Available online: https://www.who.int/health-topics/obesity.
-
- Safaei M., Sundararajan E.A., Driss M., Boulila W., Shapi’i A. A Systematic Literature Review on Obesity: Understanding the Causes & Consequences of Obesity and Reviewing Various Machine Learning Approaches Used to Predict Obesity. Comput. Biol. Med. 2021;136:104754. - PubMed
Publication types
LinkOut - more resources
Full Text Sources